304 related articles for article (PubMed ID: 30634453)
21. Epithelial-mesenchymal transition markers in lymph node metastases and primary breast tumors - relation to dissemination and proliferation.
Markiewicz A; Wełnicka-Jaśkiewicz M; Seroczyńska B; Skokowski J; Majewska H; Szade J; Żaczek AJ
Am J Transl Res; 2014; 6(6):793-808. PubMed ID: 25628790
[TBL] [Abstract][Full Text] [Related]
22. Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients.
Markou A; Lazaridou M; Paraskevopoulos P; Chen S; Świerczewska M; Budna J; Kuske A; Gorges TM; Joosse SA; Kroneis T; Zabel M; Sedlmayr P; Alix-Panabières C; Pantel K; Lianidou ES
Clin Chem; 2018 Feb; 64(2):297-306. PubMed ID: 29122836
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of epithelial-mesenchymal transition circulating tumor cells in female breast cancer: A meta-analysis.
Zhao Q; Li B; Gao Q; Luo Y; Ming L
Front Oncol; 2022; 12():1024783. PubMed ID: 36530995
[TBL] [Abstract][Full Text] [Related]
24. Discriminating Epithelial to Mesenchymal Transition Phenotypes in Circulating Tumor Cells Isolated from Advanced Gastrointestinal Cancer Patients.
Carneiro A; Piairo P; Teixeira A; Ferreira D; Cotton S; Rodrigues C; Chícharo A; Abalde-Cela S; Santos LL; Lima L; Diéguez L
Cells; 2022 Jan; 11(3):. PubMed ID: 35159186
[TBL] [Abstract][Full Text] [Related]
25. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
[TBL] [Abstract][Full Text] [Related]
26. Distribution of circulating tumor cell phenotype in early cervical cancer.
Pan L; Yan G; Chen W; Sun L; Wang J; Yang J
Cancer Manag Res; 2019; 11():5531-5536. PubMed ID: 31354357
[No Abstract] [Full Text] [Related]
27. EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy.
Chebouti I; Kasimir-Bauer S; Buderath P; Wimberger P; Hauch S; Kimmig R; Kuhlmann JD
Oncotarget; 2017 Jul; 8(30):48820-48831. PubMed ID: 28415744
[TBL] [Abstract][Full Text] [Related]
28. Phenotypes of circulating tumour cells predict time to castration resistance in metastatic castration-sensitive prostate cancer.
Yang YJ; Kong YY; Li GX; Wang Y; Ye DW; Dai B
BJU Int; 2019 Aug; 124(2):258-267. PubMed ID: 30536520
[TBL] [Abstract][Full Text] [Related]
29. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
[TBL] [Abstract][Full Text] [Related]
30. Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients.
Chen J; Cao SW; Cai Z; Zheng L; Wang Q
Cancer Biomark; 2017 Dec; 20(4):487-498. PubMed ID: 28869439
[TBL] [Abstract][Full Text] [Related]
31. Spatial heterogeneity in epithelial to mesenchymal transition properties of circulating tumor cells associated with distant recurrence in pancreatic cancer patients.
Dong X; Ma Y; Zhao X; Tian X; Sun Y; Yang Y; Zhao X
Ann Transl Med; 2020 Jun; 8(11):676. PubMed ID: 32617296
[TBL] [Abstract][Full Text] [Related]
32. Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition.
Lowes LE; Allan AL
Adv Clin Chem; 2018; 83():121-181. PubMed ID: 29304900
[TBL] [Abstract][Full Text] [Related]
33. Epithelial-mesenchymal transition and GALC expression of circulating tumor cells indicate metastasis and poor prognosis in non-small cell lung cancer.
Liu DG; Xue L; Li J; Yang Q; Peng JZ
Cancer Biomark; 2018; 22(3):417-426. PubMed ID: 29758927
[TBL] [Abstract][Full Text] [Related]
34. Clinical Significance of Circulating Tumor Cell Induced Epithelial-Mesenchymal Transition in Patients with Metastatic Colorectal Cancer by Single-Cell RNA-Sequencing.
Kozuka M; Battaglin F; Jayachandran P; Wang J; Arai H; Soni S; Zhang W; Hirai M; Matsusaka S; Lenz HJ
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638346
[TBL] [Abstract][Full Text] [Related]
35. Impact of circulating tumour cells on survival of eribulin-treated patients with metastatic breast cancer.
Ito M; Horimoto Y; Tokuda E; Murakami F; Uomori T; Himuro T; Nakai K; Orihata G; Iijima K; Saito M
Med Oncol; 2019 Sep; 36(10):89. PubMed ID: 31520329
[TBL] [Abstract][Full Text] [Related]
36. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer.
Hyun KA; Koo GB; Han H; Sohn J; Choi W; Kim SI; Jung HI; Kim YS
Oncotarget; 2016 Apr; 7(17):24677-87. PubMed ID: 27013581
[TBL] [Abstract][Full Text] [Related]
37. Membrane Hsp70-A Novel Target for the Isolation of Circulating Tumor Cells After Epithelial-to-Mesenchymal Transition.
Breuninger S; Stangl S; Werner C; Sievert W; Lobinger D; Foulds GA; Wagner S; Pickhard A; Piontek G; Kokowski K; Pockley AG; Multhoff G
Front Oncol; 2018; 8():497. PubMed ID: 30443493
[TBL] [Abstract][Full Text] [Related]
38. Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype.
Hamilton G; Hochmair M; Rath B; Klameth L; Zeillinger R
Cell Adh Migr; 2016 Jul; 10(4):360-7. PubMed ID: 26919626
[TBL] [Abstract][Full Text] [Related]
39. Circulating tumour cells and the epithelial mesenchymal transition in colorectal cancer.
Lim SH; Becker TM; Chua W; Ng WL; de Souza P; Spring KJ
J Clin Pathol; 2014 Oct; 67(10):848-53. PubMed ID: 25008452
[TBL] [Abstract][Full Text] [Related]
40. Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis.
Liu X; Li J; Cadilha BL; Markota A; Voigt C; Huang Z; Lin PP; Wang DD; Dai J; Kranz G; Krandick A; Libl D; Zitzelsberger H; Zagorski I; Braselmann H; Pan M; Zhu S; Huang Y; Niedermeyer S; Reichel CA; Uhl B; Briukhovetska D; Suárez J; Kobold S; Gires O; Wang H
Sci Adv; 2019 Jun; 5(6):eaav4275. PubMed ID: 31223646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]